Search

Your search keyword '"Ishikawa, Hiroto"' showing total 488 results
Start Over Author "Ishikawa, Hiroto"
488 results on '"Ishikawa, Hiroto"'

52. Vision

Author

Ishikawa, Hiroto, primary, Ikeda, Naohiro, additional, Kanno, Sanae, additional, Ikeda, Tomohiro, additional, Mimura, Osamu, additional, and Dezawa, Mari, additional

Published
2010
Full Text
View/download PDF

56. Characteristics of Japanese patients with Leber’s hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study

Author

Ishikawa, Hiroto, primary, Masuda, Yoichiro, additional, Ishikawa, Hitoshi, additional, Shikisima, Keigo, additional, Goseki, Toshiaki, additional, Kezuka, Takeshi, additional, Terao, Masahiko, additional, Miyazaki, Atsushi, additional, Matsumoto, Kenji, additional, Nishikawa, Hiroki, additional, Gomi, Fumi, additional, and Mimura, Osamu, additional

Published
2020
Full Text
View/download PDF

61. Real-world management of treatment-naïve diabetic macular oedema: 2-year visual outcome focusing on the starting year of intervention from STREAT-DMO study

Author

Shimura, Masahiko, primary, Kitano, Shigehiko, additional, Muramatsu, Daisuke, additional, Fukushima, Harumi, additional, Takamura, Yoshihiro, additional, Matsumoto, Makiko, additional, Kokado, Masahide, additional, Kogo, Jiro, additional, Sasaki, Mariko, additional, Morizane, Yuki, additional, Utsumi, Takuya, additional, Koto, Takashi, additional, Sonoda, Shozo, additional, Hirano, Takao, additional, Ishikawa, Hiroto, additional, Mitamura, Yoshinori, additional, Okamoto, Fumiki, additional, Kinoshita, Takamasa, additional, Kimura, Kazuhiro, additional, Sugimoto, Masahiko, additional, Yamashiro, Kenji, additional, Suzuki, Yukihiko, additional, Hikichi, Taiichi, additional, Washio, Noriaki, additional, Sato, Tomohito, additional, Ohkoshi, Kishiko, additional, Tsujinaka, Hiroki, additional, Kusuhara, Sentaro, additional, Kondo, Mineo, additional, Takagi, Hitoshi, additional, Murata, Toshinori, additional, and Sakamoto, Taiji, additional

Published
2020
Full Text
View/download PDF

69. Intraocular pressure elevation after subtenon triamcinolone acetonide injection : Multicentre retrospective cohort study in Japan

Author

Maeda, Yuki, Ishikawa, Hiroto, Nishikawa, Hiroki, Shimizu, Miho, Kinoshita, Takamasa, Ogihara, Rie, Kitano, Shigehiko, Yamanaka, Chihiro, Mitamura, Yoshinori, Sugimoto, Masahiko, Kondo, Mineo, Takamura, Yoshihiro, Ogata, Nahoko, Ikeda, Tomohiro, Gomi, Fumi, Maeda, Yuki, Ishikawa, Hiroto, Nishikawa, Hiroki, Shimizu, Miho, Kinoshita, Takamasa, Ogihara, Rie, Kitano, Shigehiko, Yamanaka, Chihiro, Mitamura, Yoshinori, Sugimoto, Masahiko, Kondo, Mineo, Takamura, Yoshihiro, Ogata, Nahoko, Ikeda, Tomohiro, and Gomi, Fumi

Abstract

Purpose To evaluate real-world evidence for intraocular pressure (IOP) elevation after subtenon triamcinolone acetonide injection (STTA) in 1252 Japanese patients (1406 eyes) in the Japan Clinical REtina STudy group (J-CREST). Methods This was a multicentre retrospective study of the medical records of 1252 patients (676 men (758 eyes); mean age: 63.8 ± 12.9 years) who received STTA in participating centres between April 2013 and July 2017. Results IOP elevation was observed in 206 eyes (14.7%) and IOP increase ≥ 6 mmHg was found in 328 eyes (23.3%). In total, 106 eyes (7.5%) needed medication and two eyes (0.14%) needed surgical procedures. Younger age, higher baseline IOP, and steroid dose were risk factors associated with IOP elevation. Risk factors associated with IOP increase ≥ 6 mmHg were younger age, lower baseline IOP, steroid dose, and higher incidences of diabetic macular oedema (DME) and uveitis. In contrast, with steroid dose fixed at 20 mg, a lower incidence of DME was a risk factor for increased IOP, suggesting that STTA had dose-dependent effects on IOP increase, especially in patients with DME. Conclusion Our real-world evidence from a large sample of Japanese patients who received STTA showed that the incidence of IOP elevation after STTA was 14.7%, and was associated with younger age, higher baseline IOP, and steroid dose. Thus, IOP should be monitored, especially in patients with younger age, higher baseline IOP, and higher incidences of DME and uveitis.

Published
2019

70. Central serous chorioretinopathy with and without steroids : A multicenter survey

Author

Araki, Takashi, Ishikawa, Hiroto, Iwahashi, Chiharu, Niki, Masanori, Mitamura, Yoshinori, Sugimoto, Masahiko, Kondo, Mineo, Kinoshita, Takamasa, Nishi, Tomo, Ueda, Tetsuo, Kato, Aki, Yasukawa, Tsutomu, Takamura, Yoshihiro, Gomi, Fumi, Araki, Takashi, Ishikawa, Hiroto, Iwahashi, Chiharu, Niki, Masanori, Mitamura, Yoshinori, Sugimoto, Masahiko, Kondo, Mineo, Kinoshita, Takamasa, Nishi, Tomo, Ueda, Tetsuo, Kato, Aki, Yasukawa, Tsutomu, Takamura, Yoshihiro, and Gomi, Fumi

Abstract

We investigated the rates of the use of steroids in Japanese central serous chorioretinopathy (CSC) cases and differences in the characteristics of CSC with and without steroids. A total of 538 eyes of 477 patients diagnosed with CSC, with 3 months or more of follow-up between April 2013 and June 2017 at 8 institutions. Patients with CSC with more than 3 months of follow-up were identified by OCT and fluorescein angiography at 8 institutions. Data collected included patient demographics, history of corticosteroid medication and smoking, spherical errors, findings of angiography, subfoveal choroidal thickness, and changes through the follow-up period. Differences in these findings were analyzed in cases with and without corticosteroid treatment. Among the 477 patients (344 men,133 women), 74 (15.5%) (39 men, 35 women) underwent current or prior steroid treatment. Cases with steroids were higher age (p = 0.0403) and showed no male prevalence, more bilateral involvement (p < 0.0001), and the affected eyes had multiple pigment epithelial detachment (p <0.0001), more fluorescein leakage sites (p < 0.0001), greater choroidal thickness (p = 0.0287) and a higher recurrence rate (p = 0.0412). Steroids can cause severer CSC through an effect on choroidal vessels and an impairment of retinal pigment epithelium.

Published
2019

71. Real-world management of treatment-naïve diabetic macular oedema in Japan : two-year visual outcomes with and without anti-VEGF therapy in the STREAT-DME study

Author

Shimura, Masahiko, Kitano, Shigehiko, Muramatsu, Daisuke, Fukushima, Harumi, Takamura, Yoshihiro, Matsumoto, Makiko, Kokado, Masahide, Kogo, Jiro, Sasaki, Mariko, Morizane, Yuki, Kotake, Osamu, Koto, Takashi, Sonoda, Shozo, Hirano, Takao, Ishikawa, Hiroto, Mitamura, Yoshinori, Okamoto, Fumiki, Kinoshita, Takamasa, Kimura, Kazuhiro, Sugimoto, Masahiko, Yamashiro, Kenji, Suzuki, Yukihiko, Hikichi, Taiichi, Washio, Noriaki, Sato, Tomohito, Ohkoshi, Kishiko, Tsujinaka, Hiroki, Kusuhara, Sentaro, Kondo, Mineo, Takagi, Hitoshi, Murata, Toshinori, Sakamoto, Taiji, Shimura, Masahiko, Kitano, Shigehiko, Muramatsu, Daisuke, Fukushima, Harumi, Takamura, Yoshihiro, Matsumoto, Makiko, Kokado, Masahide, Kogo, Jiro, Sasaki, Mariko, Morizane, Yuki, Kotake, Osamu, Koto, Takashi, Sonoda, Shozo, Hirano, Takao, Ishikawa, Hiroto, Mitamura, Yoshinori, Okamoto, Fumiki, Kinoshita, Takamasa, Kimura, Kazuhiro, Sugimoto, Masahiko, Yamashiro, Kenji, Suzuki, Yukihiko, Hikichi, Taiichi, Washio, Noriaki, Sato, Tomohito, Ohkoshi, Kishiko, Tsujinaka, Hiroki, Kusuhara, Sentaro, Kondo, Mineo, Takagi, Hitoshi, Murata, Toshinori, and Sakamoto, Taiji

Abstract

Background/Aims To investigate real-world outcomes for best-corrected visual acuity (BCVA) after 2-year clinical intervention for treatment-naïve, centr-involving diabetic macular oedema (DME). Methods Retrospective analysis of longitudinal medical records obtained from 27 institutions specialising in retinal diseases in Japan. A total of 2049 eyes with treatment-naïve DME commencing intervention between 2010 and 2015 who were followed for 2 years were eligible. Interventions for DME included anti-vascular endothelial growth factor (VEGF) therapy, local corticosteroid therapy, macular photocoagulation and vitrectomy. Baseline and final BCVA (logMAR) were assessed. Eyes were classified by the treatment pattern, depending on whether anti-VEGF therapy was used, into an anti-VEGF monotherapy group (group A), a combination therapy group (group B) and a group without anti-VEGF therapy (group C). Results The mean 2-year improvement of BCVA was −0.04±0.40 and final BCVA of >20/40 was obtained in 46.3% of eyes. Based on the treatment pattern, there were 427 eyes (20.9%) in group A, 807 eyes (39.4%) in group B and 815 eyes (39.8%) in group C. Mean improvement of BCVA was −0.09±0.39, –0.02±0.40 and −0.05±0.39, and the percentage of eyes with final BCVA of >20/40 was 49.4%, 38.9%, and 52.0%, respectively. Conclusion Following 2-year real-world management of treatment-naïve DME in Japan, BCVA improved by 2 letters. Eyes treated by anti-VEGF monotherapy showed a better visual prognosis than eyes receiving combination therapy. Despite treatment for DME being selected by specialists in consideration of medical and social factors, a satisfactory visual prognosis was not obtained, but final BCVA remained >20/40 in half of all eyes.

Published
2019

75. Intraocular pressure elevation after subtenon triamcinolone acetonide injection; Multicentre retrospective cohort study in Japan

Author

Maeda, Yuki, primary, Ishikawa, Hiroto, additional, Nishikawa, Hiroki, additional, Shimizu, Miho, additional, Kinoshita, Takamasa, additional, Ogihara, Rie, additional, Kitano, Shigehiko, additional, Yamanaka, Chihiro, additional, Mitamura, Yoshinori, additional, Sugimoto, Masahiko, additional, Kondo, Mineo, additional, Takamura, Yoshihiro, additional, Ogata, Nahoko, additional, Ikeda, Tomohiro, additional, and Gomi, Fumi, additional

Published
2019
Full Text
View/download PDF

76. Real-world management of treatment-naïve diabetic macular oedema in Japan: two-year visual outcomes with and without anti-VEGF therapy in the STREAT-DME study

Author

Shimura, Masahiko, primary, Kitano, Shigehiko, additional, Muramatsu, Daisuke, additional, Fukushima, Harumi, additional, Takamura, Yoshihiro, additional, Matsumoto, Makiko, additional, Kokado, Masahide, additional, Kogo, Jiro, additional, Sasaki, Mariko, additional, Morizane, Yuki, additional, Kotake, Osamu, additional, Koto, Takashi, additional, Sonoda, Shozo, additional, Hirano, Takao, additional, Ishikawa, Hiroto, additional, Mitamura, Yoshinori, additional, Okamoto, Fumiki, additional, Kinoshita, Takamasa, additional, Kimura, Kazuhiro, additional, Sugimoto, Masahiko, additional, Yamashiro, Kenji, additional, Suzuki, Yukihiko, additional, Hikichi, Taiichi, additional, Washio, Noriaki, additional, Sato, Tomohito, additional, Ohkoshi, Kishiko, additional, Tsujinaka, Hiroki, additional, Kusuhara, Sentaro, additional, Kondo, Mineo, additional, Takagi, Hitoshi, additional, Murata, Toshinori, additional, and Sakamoto, Taiji, additional

Published
2019
Full Text
View/download PDF

79. Empathy in stroke rats is modulated by social settings

Author

Shinozuka, Kazutaka, primary, Tajiri, Naoki, additional, Ishikawa, Hiroto, additional, Tuazon, Julian P, additional, Lee, Jea-Young, additional, Sanberg, Paul R, additional, Zarriello, Sydney, additional, Corey, Sydney, additional, Kaneko, Yuji, additional, and Borlongan, Cesario V, additional

Published
2019
Full Text
View/download PDF

80. Sinusoidal Obstruction Syndrome and Postoperative Complications Resulting from Preoperative Chemotherapy for Colorectal Cancer Liver Metastasis

Author

HISAKA, TORU, primary, ISHIKAWA, HIROTO, additional, SAKAI, HISAMUNE, additional, KAWAHARA, RYUICHI, additional, GOTO, YUICHI, additional, NOMURA, YORIKO, additional, YASUNAGA, MASAFUMI, additional, KINUGASA, TETSUSHI, additional, FUJITA, FUMIHIKO, additional, MIZOBE, TOMOAKI, additional, FUKAHORI, MASARU, additional, MIWA, KEISUKE, additional, NAKASHIMA, OSAMU, additional, TANIGAWA, MASAHIKO, additional, NAITO, YOSHIKI, additional, AKIBA, JUN, additional, YANO, HIROHISA, additional, TANAKA, HIROYUKI, additional, AKAGI, YOSHITO, additional, and OKUDA, KOJI, additional

Published
2019
Full Text
View/download PDF

81. Expression of Matrix Metalloproteinases in Intraductal Papillary Mucinous Neoplasm of the Pancreas

Author

AKASHI, MASANORI, primary, HISAKA, TORU, additional, SAKAI, HISAMUNE, additional, ISHIKAWA, HIROTO, additional, KAWAHARA, RYUICHI, additional, GOTO, YUICHI, additional, NOMURA, YORIKO, additional, YASUNAGA, MASAFUMI, additional, FUJITA, FUMIHIKO, additional, TANIGAWA, MASAHIKO, additional, NAITO, YOSHIKI, additional, AKIBA, JUN, additional, YANO, HIROHISA, additional, TANAKA, HIROYUKI, additional, AKAGI, YOSHITO, additional, and OKUDA, KOJI, additional

Published
2019
Full Text
View/download PDF

82. Clinicopathological Study of Resections of Intraductal Papillary Neoplasm of the Bile Duct

Author

SATO, TOSHIHIRO, primary, HISAKA, TORU, additional, SAKAI, HISAMUNE, additional, ISHIKAWA, HIROTO, additional, KAWAHARA, RYUICHI, additional, GOTO, YUICHI, additional, NOMURA, YORIKO, additional, YASUNAGA, MASAFUMI, additional, FUJITA, FUMIHIKO, additional, TANIGAWA, MASAHIKO, additional, NAITO, YOSHIKI, additional, AKIBA, JUN, additional, YANO, HIROHISA, additional, TANAKA, HIROYUKI, additional, AKAGI, YOSHITO, additional, and OKUDA, KOJI, additional

Published
2019
Full Text
View/download PDF

83. Clinical and Prognostic Significance of Neoplastic Spindle Cells in Gallbladder Cancer

Author

MIDORIKAWA, RYUTA, primary, HISAKA, TORU, additional, SAKAI, HISAMUNE, additional, NOMURA, YORIKO, additional, GOTO, YUICHI, additional, SATO, TOSHIHIRO, additional, KAWAHARA, RYUICHI, additional, ISHIKAWA, HIROTO, additional, FUJITA, FUMIHIKO, additional, YASUNAGA, MASAFUMI, additional, TANIGAWA, MASAHIKO, additional, NAITO, YOSHIKI, additional, AKIBA, JUN, additional, YANO, HIROHISA, additional, TANAKA, HIROYUKI, additional, AKAGI, YOSHITO, additional, and OKUDA, KOJI, additional

Published
2019
Full Text
View/download PDF

85. Significance of neoadjuvant chemoradiotherapy for borderline resectable pancreatic head cancer: Pathological local invasion and microvessel invasion analysis

Author

Naito, Yoshiki, primary, Ishikawa, Hiroto, additional, Sadashima, Eiji, additional, Okabe, Yoshinobu, additional, Takahashi, Kenjiro, additional, Kawahara, Ryuichi, additional, Hisaka, Toru, additional, Fukahori, Masaru, additional, Ushijima, Tomoyuki, additional, Ishida, Yusuke, additional, Tanigawa, Masahiko, additional, Mihara, Yutaro, additional, Nakayama, Masamichi, additional, Kondo, Reiichiro, additional, Kusano, Hironori, additional, Takase, Yorihiko, additional, Abe, Hideyuki, additional, Ogo, Etsuyo, additional, Okuda, Koji, additional, Shimamatsu, Kazuhide, additional, Yano, Hirohisa, additional, and Akiba, Jun, additional

Published
2019
Full Text
View/download PDF

87. Central serous chorioretinopathy with and without steroids: A multicenter survey

Author

Araki, Takashi, primary, Ishikawa, Hiroto, additional, Iwahashi, Chiharu, additional, Niki, Masanori, additional, Mitamura, Yoshinori, additional, Sugimoto, Masahiko, additional, Kondo, Mineo, additional, Kinoshita, Takamasa, additional, Nishi, Tomo, additional, Ueda, Tetsuo, additional, Kato, Aki, additional, Yasukawa, Tsutomu, additional, Takamura, Yoshihiro, additional, and Gomi, Fumi, additional

Published
2019
Full Text
View/download PDF

88. Scleral buckling versus vitrectomy for young japanese patients with rhegmatogenous retinal detachment in the era of microincision surgery: real‐world evidence from a multicentre study in Japan

Author

Shu, Ingen, primary, Ishikawa, Hiroto, additional, Nishikawa, Hiroki, additional, Morikawa, Shohei, additional, Okamoto, Fumiki, additional, Sakamoto, Taiji, additional, Sugimoto, Masahiko, additional, Kondo, Mineo, additional, Iwasaki, Masanori, additional, Kinoshita, Takamasa, additional, Toibana, Toshi, additional, Mitamura, Yoshinori, additional, Takamura, Yoshihiro, additional, Motohashi, Ryosuke, additional, Shimura, Masahiko, additional, Sakurai, Yutaka, additional, Takeuchi, Masaru, additional, and Gomi, Fumi, additional

Published
2019
Full Text
View/download PDF

90. Clinical preferences and trends of anti‐vascular endothelial growth factor treatments for diabetic macular edema in Japan

Author

Sugimoto, Masahiko, Tsukitome, Hideyuki, Okamoto, Fumiki, Oshika, Tetsuro, Ueda, Tetsuo, Niki, Masanori, Mitamura, Yoshinori, Ishikawa, Hiroto, Gomi, Fumi, Kitano, Shigehiko, Noma, Hidetaka, Shimura, Masahiko, Sonoda, Shozo, Sawada, Osamu, Ohji, Masahito, Harimoto, Kozo, Takeuchi, Masaru, Takamura, Yoshihiro, Kondo, Mineo, Sakamoto, Taiji, Sugimoto, Masahiko, Tsukitome, Hideyuki, Okamoto, Fumiki, Oshika, Tetsuro, Ueda, Tetsuo, Niki, Masanori, Mitamura, Yoshinori, Ishikawa, Hiroto, Gomi, Fumi, Kitano, Shigehiko, Noma, Hidetaka, Shimura, Masahiko, Sonoda, Shozo, Sawada, Osamu, Ohji, Masahito, Harimoto, Kozo, Takeuchi, Masaru, Takamura, Yoshihiro, Kondo, Mineo, and Sakamoto, Taiji

Abstract

Aims/Introduction: To determine the current clinical preferences of anti‐vascular endothelial growth factor (VEGF) treatment protocols for diabetic macular edema (DME) in Japan. Materials and Methods: This was a descriptive cross‐sectional study. Answers to a questionnaire consisting of 16 questions were obtained from 176 of 278 (63.3%) surveyed ophthalmologists. Results: The results showed that 81.2% preferred intravitreal injections of anti‐VEGF antibodies as the first‐line therapy. The most important indicators for beginning anti‐VEGF therapy were: the best‐corrected visual acuity in 44.3% and the retinal thickness in 30.7%. In the loading phase, 53.4% preferred a single injection, and in the maintenance phase, 75.0% preferred the pro re nata regimen. Financial limitation (85.8%) was reported as the most important difficulty in the treatment. For combination therapy with anti‐VEGF treatment, panretinal photocoagulation, focal photocoagulations and a sub‐Tenon steroid injection were preferred. The contraindications for anti‐VEGF therapy were: prior cerebral infarction (72.7%). Regarding the use of both approved anti‐VEGF agents in Japan, ranibizumab and aflibercept, 39.8% doctors used them appropriately. Conclusions: Our results present the current clinical preferences of anti‐VEGF treatment for DME in Japan. The best‐corrected visual acuity and the retinal thickness are important indicators to institute this therapy. The majority of the ophthalmologists use anti‐VEGF treatment as first‐line therapy and prefer the 1 + pro re nata regimen.

Published
2018

91. Flanged intraocular lens fixation via 27‐gauge trocars using a double‐needle technique decreases surgical wounds without losing its therapeutic effect.

Author

Ishikawa, Hiroto, Fukuyama, Hisashi, Komuku, Yuki, Araki, Takashi, and Gomi, Fumi

Subjects
*SURGICAL site, *INTRAOCULAR lenses, *TREATMENT effectiveness, *OPERATIVE surgery, *VITRECTOMY, *VISUAL acuity
Abstract

Purpose: Intraocular lens (IOL) fixation using a sutureless 27‐gauge needle intrascleral IOL implantation technique requires six surgical wounds. We developed a modified technique using two 27‐gauge trocars for vitrectomy and indwelling flanged IOL haptics to reduce the number of surgical wounds. Setting: Department of Ophthalmology, Hyogo College of Medicine. Design: This retrospective study enrolled 54 patients who had undergone IOL scleral fixation between January 2016 and April 2019. Methods: Patients who underwent IOL scleral fixation and were observed for >12 weeks were analysed using medical record data. Before October 2017, patients underwent normal flanged IOL scleral fixation. Between November 2017 and April 2019, patients underwent the modified method (flanged IOL via 27‐gauge trocars with double‐needle technique). Primary end‐point was superiority or non‐inferiority of modified IOL scleral fixation compared with normal IOL scleral fixation for visual acuity (VA). Changes in corneal endothelium cell number, refractivity, astigmatisms and surgery‐related complications, were secondary end‐points. Results: There were no significant differences in baseline characteristics between groups. Raw VA and best collected VA (BCVA) were significantly improved in all eyes (p−). There were no statistical significances in raw VA, BCVA and surgery‐related complications between groups. Conclusions: Results of the modified technique were not inferior compared with the original technique although it was less invasive. Therefore, flanged IOL fixation via trocars using a double‐needle technique is a useful technique for IOL implantation. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

93. PD-L1 expression in pancreatic adenosquamous carcinoma: PD-L1 expression is limited to the squamous component

Author

Tanigawa, Masahiko, primary, Naito, Yoshiki, additional, Akiba, Jun, additional, Kawahara, Akihiko, additional, Okabe, Yoshinobu, additional, Ishida, Yusuke, additional, Ishikawa, Hiroto, additional, Hisaka, Toru, additional, Fujita, Fumihiko, additional, Yasunaga, Masafumi, additional, Shigaki, Takahiro, additional, Sudo, Tomoya, additional, Mihara, Yutaro, additional, Nakayama, Masamichi, additional, Kondo, Reiichiro, additional, Kusano, Hironori, additional, Shimamatsu, Kazuhide, additional, Okuda, Koji, additional, Akagi, Yoshito, additional, and Yano, Hirohisa, additional

Published
2018
Full Text
View/download PDF

95. Clinical preferences and trends of anti‐vascular endothelial growth factor treatments for diabetic macular edema in Japan

Author

Sugimoto, Masahiko, primary, Tsukitome, Hideyuki, additional, Okamoto, Fumiki, additional, Oshika, Tetsuro, additional, Ueda, Tetsuo, additional, Niki, Masanori, additional, Mitamura, Yoshinori, additional, Ishikawa, Hiroto, additional, Gomi, Fumi, additional, Kitano, Shigehiko, additional, Noma, Hidetaka, additional, Shimura, Masahiko, additional, Sonoda, Shozo, additional, Sawada, Osamu, additional, Ohji, Masahito, additional, Harimoto, Kozo, additional, Takeuchi, Masaru, additional, Takamura, Yoshihiro, additional, Kondo, Mineo, additional, and Sakamoto, Taiji, additional

Published
2018
Full Text
View/download PDF

96. FinD

Author

Ishikawa, Hiroto, primary, Hara, Michiki, additional, Takahashi, Wataro, additional, and Tobe, Yoshito, additional

Published
2018
Full Text
View/download PDF

98. Combined therapy with gemcitabine hydrochloride and nanoparticle albumin-bound paclitaxel enabled resection in a patient with unresectable locally advanced pancreatic cancer

Author

SAKAUE, Takahiko, primary, FUKAHORI, Masaru, additional, MIWA, Keisuke, additional, USHIJIMA, Tomoyuki, additional, YASUMOTO, Makiko, additional, KURAOKA, Kei, additional, ISHIDA, Yuusuke, additional, NAGASU, Sachiko, additional, ISHIKAWA, Hiroto, additional, MIHARA, Yuutarou, additional, NAKAYAMA, Masamichi, additional, NAITOU, Yoshiki, additional, OKABE, Yoshinobu, additional, and TORIMURA, Takuji, additional

Published
2018
Full Text
View/download PDF

99. Abstract 4762: Clinicopathologic findings of borderline resectable pancreatic cancer after neoadjuvant chemoradiotherapy

Author

Naito, Yoshiki, primary, Nakayama, Masamichi, additional, Ishikawa, Hiroto, additional, Takahashi, Kenjiro, additional, Hisaka, Toru, additional, Okuda, Koji, additional, Fukahori, Masaru, additional, Ishida, Yusuke, additional, Okabe, Yoshinobu, additional, Mihara, Yutaro, additional, Tanigawa, Masahiko, additional, Akiba, Jun, additional, Torimura, Takuji, additional, and Yano, Hirohisa, additional

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results